Blog
Commentary: Efficacy and Safety of Oral Roflumilast for Moderate to Severe Psoriasis—A Randomized Controlled Trial…
In this blog post, we examine the findings of a randomized controlled trial investigating the efficacy and safety of…
Read More
Matías
Maskin
,
MD
Assistant Professor Dermatology
CEMIC University, at Buenos Aires
Buenos Aires
,
Argentina
Dr. Matias Maskin is Assistant Professor at the Section of Dermatology, Department of Medicine, Centro de Educacion Medica e Investigaciones Clinicas (CEMIC) University, at Buenos Aires. He specializes in internal medicine and dermatology at the University of Buenos Aires and serves as Chief of Dermatology and Coordinator of the psoriasis section at the Instituto Universitario CEMIC. Dr. Maskin is a founding member of the Latin American Society of Psoriasis (SOLAPSO), is active in psoriasis education programs with SOLAPSO in Argentina, and is part of the SOLAPSO Biosimilars Consensus in Argentina. A member of IPC’s Latin America working group, Dr. Maskin has authored national and international publications, has served as an investigator for many psoriasis clinical trials, and has participated in many national and international congress presentations pertaining to psoriasis.
Last Updated:
05/04/2022
Areas of Interest
Tbc epidemiology and psoriasis treatment.
IPC Committees / Groups
Editorial Committee, Latin America Working Group
Languages Spoken
English, Spanish
Involvement with Other Organization(s)
Medical advisor to Asociación Civil para el Enfermo de Psoriasis (AEPSO).
